inducement grants

Cue Biopharma grants inducement equity to new President and CEO Dr. Shao-Lee Lin and six employees under Nasdaq rules, signaling leadership transition and growth strategy.

NewAmsterdam Pharma approved inducement grants totaling 50,400 options and 15,400 RSUs to five new non-executive employees under Nasdaq compliance rules.

Intellia Therapeutics grants 67,150 RSUs to 13 new employees under Nasdaq inducement rules, signaling active talent acquisition in competitive gene-editing sector.

NewAmsterdam Pharma grants 15,000 options and 3,200 RSUs to two new executives, complying with Nasdaq listing regulations.

Vor Bio awarded stock options and RSUs to nine newly hired employees as employment inducements, with options exercisable at $17.39 per share over a 10-year term.

Penguin Solutions awards equity package including RSUs and performance-based PSUs to new Chief Product Officer, signaling strategic investment in product leadership.

BioCryst awards 65,850 RSUs to six new employees under Nasdaq inducement rule, vesting over four years starting March 2027.

TELA Bio granted 8,550 restricted stock units to three new hires, vesting over four years. The equity compensation aims to attract talent and promote retention.